Skip to main content
MEDICLINIC INTERNATIONAL PLC logo

MEDICLINIC INTERNATIONAL PLC — Investor Relations & Filings

Ticker · MDC ISIN · US58471Q1004 LEI · 2138002S5BSBIZTD5I60 IL Human health and social work activities
Open in API
Filings indexed 628 across all filing types
Latest filing 2022-12-06 Director's Dealing
Country GB United Kingdom
Listing IL MDC

About MEDICLINIC INTERNATIONAL PLC

https://www.mediclinic.com/en/home.html

Mediclinic International PLC is a diversified international private healthcare services group focused on providing specialist-orientated, multi-disciplinary services across the continuum of care. The company's clinical offerings include acute care, outpatient consultations, pre-hospital emergency services, day case surgery, and inpatient care. With a core purpose to enhance the quality of life, the group emphasizes delivering high-quality, patient-centric healthcare. Mediclinic operates with a sustainable, long-term approach, upholding high standards of clinical governance and investing in skilled professionals, advanced facilities, and modern medical equipment to be a trusted provider for clients, medical practitioners, and funders.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is an official notification filed via RNS (London Stock Exchange's news service). The title explicitly states: 'NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM'. This type of filing details insider trading or transactions by directors/executives (PDMRs). This directly corresponds to the definition for Director's Dealing (DIRS). Although it is distributed via RNS, the specific content dictates the DIRS classification over the general RNS fallback.
2022-12-06 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'FORM 8.3 - Mediclinic International plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a Public Opening Position Disclosure/Dealing Disclosure made by a person holding 1% or more interests in relevant securities during a takeover situation. This type of disclosure relates to insider dealings or significant ownership changes during a takeover bid, which aligns most closely with the 'Director's Dealing' (DIRS) category, as it reports on interests and dealings of a significant party involved in the securities of the target company (Mediclinic International plc) during a potential takeover scenario. While it is not strictly a director's dealing, it is a mandatory disclosure of interests/dealings related to a takeover, which is a specific type of insider/major shareholder activity. Given the options, 'DIRS' (Director's Dealing) is the closest fit for mandatory disclosure of personal/firm security interests/transactions, although 'TAR' (M&A Activity) is also relevant due to the reference to the Takeover Code. However, Form 8.3 is fundamentally a disclosure of position/dealing, making DIRS the better fit among the provided choices for reporting security interests/transactions, even if the entity is a fund manager rather than a director. Since the document details positions and dealings under the Takeover Code, it is a specific type of insider/major shareholder disclosure.
2022-12-05 English
Form 8.3 - Mediclinic International plc
M&A Activity Classification · 1% confidence The document is explicitly titled 'FORM 8.3 - Mediclinic International plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE'. This type of disclosure relates directly to an ongoing takeover or merger activity involving the target company (Mediclinic International plc). Among the provided definitions, the category that best covers documents related to takeover bids and merger proposals is 'M&A Activity' (Code: TAR). Although this is a specific regulatory filing related to a takeover, TAR is the most appropriate thematic classification for documents detailing interests/dealings during a takeover process.
2022-12-02 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'FORM 8.3 - Mediclinic International plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a Public Opening Position Disclosure/Dealing Disclosure made by a person holding 1% or more interest in relevant securities during a takeover situation. This type of disclosure relates directly to insider/significant shareholder dealings during a takeover/merger event. While it involves dealings, the specific context of the Takeover Code (Rule 8.3) points towards disclosures related to M&A activity or insider transactions during a bid. Since the definitions include 'Director's Dealing (DIRS)' and 'M&A Activity (TAR)', I must choose the most specific fit. Rule 8.3 disclosures are mandatory during a takeover/offer period. Given the explicit reference to the 'Takeover Code' and the disclosure of positions/dealings related to an 'offeror/offeree', this is most closely aligned with M&A Activity (TAR), as it is a direct consequence of a takeover situation. However, the core content is about the director/insider's position and dealings. Since 'Director's Dealing (DIRS)' is defined as 'Report of personal share transactions by company directors and executives (insider trades)', and this form reports the position and dealings of a significant shareholder (Millennium International Management LP) in the context of an offer, it falls under the broader category of insider/significant shareholder transaction reporting during a corporate action. In many regulatory contexts, these specific takeover disclosures (Form 8.3) are often grouped with insider dealing reports or M&A filings. Given the options, 'Director's Dealing (DIRS)' covers insider transactions, and 'M&A Activity (TAR)' covers takeover-related documents. Since this is a mandatory disclosure *because* of an offer, TAR is highly relevant. However, Form 8.3 is fundamentally about reporting ownership/dealings by a person with a significant interest. If the document were solely about a director's routine trade outside a bid, DIRS would fit. Because it is tied to the 'Takeover Code' and an 'offeror/offeree', TAR is the better fit for the context of the filing, as it is a document generated specifically due to the M&A event.
2022-12-01 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'FORM 8.3 - Mediclinic International plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE'. This type of disclosure relates to insider transactions or significant ownership changes during a takeover or merger situation. Among the provided categories, 'Director's Dealing (Code: DIRS)' covers personal share transactions by executives, and 'M&A Activity (Code: TAR)' covers merger proposals or takeover bids. Since this filing is directly mandated by the Takeover Code (Rule 8.3) concerning interests in securities during an offer, it is most closely related to the M&A/Takeover context (TAR). However, the specific nature of the filing (disclosure of interests/dealings by a significant shareholder/stakeholder during an offer) is a specialized regulatory filing related to insider activity during a takeover. Given the options, 'Director's Dealing (DIRS)' covers insider trades, but this is broader than just directors. 'M&A Activity (TAR)' covers the context (takeover). Since this is a mandatory disclosure related to a potential or ongoing takeover bid (implied by the Takeover Code reference), TAR is the most contextually appropriate classification, as it signals activity directly related to a takeover scenario. If TAR was not available, DIRS might be considered, but TAR captures the regulatory environment better.
2022-11-30 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'FORM 8.3 - Mediclinic International plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a Public Opening Position Disclosure or Dealing Disclosure made by a person holding 1% or more interest in relevant securities during a takeover situation. This type of disclosure relates to insider/significant shareholder dealings during a takeover/merger scenario. Among the provided codes, 'TAR' (M&A Activity) is the most appropriate category as it covers takeover bids, and Form 8.3 is a direct regulatory requirement stemming from a takeover situation involving Mediclinic International plc. While 'DIRS' covers director dealings, Form 8.3 is specific to takeover code compliance, making 'TAR' a better fit for the context of the filing.
2022-11-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.